FDA Vulnerable To Meddling In Climate Of Distrust – Commish Hamburg
This article was originally published in The Rose Sheet
Executive Summary
An atmosphere of distrust in government makes FDA vulnerable to congressional meddling, Commissioner Margaret Hamburg suggested in a July 25 presentation to consumer group Public Citizen.
You may also be interested in...
FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg
FDA is considering further “modulations” of its current approaches to drug approvals in order to encourage innovation and get products to market more quickly, Commissioner Margaret Hamburg commented during a panel session at the Biotechnology Industry Organization International Convention in Washington, D.C. on June 28.
House Cuts WIC Funding In Appropriations Bill
The House passes a fiscal 2012 appropriations bill with significant cuts to a program that provides infant formula for low-income women.
US FDA Commissioner Califf Takes On Misinformation, Starting With ‘Rumor Control’
Agency leader expects to spend about a year developing a strategy to combat misinformation. On 5 August, the agency unveiled what appears to be an early component of the initiative – a web page titled Rumor Control, with facts about the safety and components of COVID-19 vaccines.